C Rad AB

C Rad AB maintains a strong liquidity position with a current ratio of 2.84, indicating the company can cover its short-term obligations more than two and a half times over. The company's debt-to-equity ratio is 0.01, reflecting a minimal reliance on debt financing and a conservative capital structure. However, the risk assessment notes that net cash is negative after subtracting total debt, suggesting potential liquidity constraints if short-term obligations increase. In terms of profitability, C Rad AB reported a net income of 16.1 million SEK, with a return on equity (ROE) of 5.53% and a return on assets (ROA) of 3.75%. These figures indicate moderate profitability relative to its equity and asset base. The company's operating income of 14.2 million SEK and gross profit of 49.9 million SEK suggest a healthy margin structure, although the ROE and ROA are below the industry median for advanced medical equipment and technology firms. C Rad AB's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher concentration risk, particularly if demand in its primary market fluctuates. Looking ahead, the company's revenue is expected to grow, supported by a positive outlook in the healthcare equipment and technology sector. Analysts have assigned a mean recommendation of 2.00, indicating a "buy" rating, with one analyst specifically recommending a "buy". The company's free cash flow of 18.4 million SEK and operating cash flow of 16.6 million SEK support its ability to fund operations and potentially invest in growth opportunities. The risk assessment highlights a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. While the company's dilution risk is currently low, the absence of a detailed dilution potential analysis in the provided data means that future capital-raising activities could introduce dilution pressure. The company's conservative debt structure and strong equity position mitigate some of these risks, but the negative net cash position remains a concern. Recent events and filings do not indicate any material changes in the company's operations or financial position. The company's financial statements and analyst estimates suggest a stable and growing business, with a focus on maintaining profitability and liquidity.